VITORA: Clinical Study to Evaluate the Effect of KB109 on the Gut Microbiome in Subjects Whose Gastrointestinal Tracts Are Colonized With Multiple Drug-resistant Organisms

Clinical trial NCT03944369 · TERMINATED

Trial details

NCT number: NCT03944369
Sponsor: Kaleido Biosciences
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Vancomycin-Resistant Enterococcus, Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae, or Carbapenem-Resistant Enterobacteriaceae Colonized Subjects

Start date: 2019-06-27
Primary completion: 2020-06-16
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.